3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
13
Brain Neoplasms
11
Lung Neoplasms
9
Neoplasm Metastasis
8
Pancreatic Neoplasms
4
Breast Neoplasms
4
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Meningioma
2
Melanoma
2
Urogenital Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Oligometastatic Prostate Cancer
1
NSCLC
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Radiosurgery
×
30 days
×
Clear all
No trials found.